Sarcocystis sp. encephalomyelitis in a cat.
A 5-month-old male neutered domestic shorthair cat was evaluated for spinal pain, ataxia, and anisocoria. Neuroanatomic localization indicated diffuse or multifocal central nervous system disease. On cerebrospinal fluid analysis, neutrophilic pleocytosis and intracellular protozoal merozoites were observed. The merozoites were oval, 2-4 microm in width and 4-6 microm in length, and had linear arrays of nuclear material concentrated at one pole. Serum was positive for Sarcocystis sp. antibodies and negative for Toxoplasma gondii antibodies. The organism was determined to be either Sarcocystis neurona or Sarcocystis dasypi based on sequence analysis of the internal transcribed spacer 1 ribosomal RNA genomic region. Clinical disease resolved following treatment with 3 different protocols for protozoal infection. This case is the first to demonstrate the antemortem diagnosis and survival of a domestic cat with Sarcocystis sp.-associated encephalomyelitis. Clinicians and cytopathologists should include Sarcocystis sp. as a differential for feline inflammatory central nervous system disease characterized by neutrophilic pleocytosis.
Bisby
Tricia M
TM
Department of Comparative Pathobiology, School of Veterinary Medicine, Purdue University, West Lafayette, IN, USA. tbisby@purdue.edu
Holman
Patricia J
PJ
Pitoc
George A
GA
Packer
Rebecca A
RA
Thompson
Craig A
CA
Raskin
Rose E
RE
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D002415:Cats; D008297:Male; D012522:Sarcocystis; D012523:Sarcocystosis / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology / Q000662:veterinary*
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents